Barclays raised the firm’s price target on Centene (CNC) to $93 from $91 and keeps an Overweight rating on the shares following the investor day. Centene’s embedded earnings supports greater than 15% annual earnings growth in 2026 and 2027, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNC:
- Adobe outlook disappoints, Kroger announces $7.5B buyback: Morning Buzz
- Morning Movers: Keros Therapeutics plummets after halting TROPOS trial dosing
- Centene Projects Strong Financial Growth for 2025
- Centene sees FY25 adjusted EPS greater than $7.25, consensus $7.05
- Centene backs FY24 adjusted EPS view greater than $6.80, consensus $6.73